nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—gout—ankylosing spondylitis	0.468	1	CtDrD
Naproxen—migraine—Prednisone—ankylosing spondylitis	0.0981	0.341	CpDpCtD
Naproxen—osteoarthritis—Prednisone—ankylosing spondylitis	0.0949	0.33	CpDpCtD
Naproxen—osteoarthritis—Methylprednisolone—ankylosing spondylitis	0.0949	0.33	CpDpCtD
Naproxen—SLCO1A2—Prednisolone—ankylosing spondylitis	0.0226	0.118	CbGbCtD
Naproxen—PTGS2—Triamcinolone—ankylosing spondylitis	0.0219	0.114	CbGbCtD
Naproxen—PTGS2—Sulfasalazine—ankylosing spondylitis	0.0219	0.114	CbGbCtD
Naproxen—SLCO1A2—Prednisone—ankylosing spondylitis	0.0213	0.111	CbGbCtD
Naproxen—PTGS2—Betamethasone—ankylosing spondylitis	0.0188	0.0978	CbGbCtD
Naproxen—PTGS1—Sulfasalazine—ankylosing spondylitis	0.0185	0.0962	CbGbCtD
Naproxen—SLCO1A2—Dexamethasone—ankylosing spondylitis	0.0133	0.0694	CbGbCtD
Naproxen—ALB—Prednisone—ankylosing spondylitis	0.011	0.0574	CbGbCtD
Naproxen—PTGS2—Dexamethasone—ankylosing spondylitis	0.0109	0.0569	CbGbCtD
Naproxen—SLCO1A2—Methotrexate—ankylosing spondylitis	0.0107	0.0558	CbGbCtD
Naproxen—SLC22A6—Methotrexate—ankylosing spondylitis	0.00649	0.0338	CbGbCtD
Naproxen—ALB—Methotrexate—ankylosing spondylitis	0.00553	0.0288	CbGbCtD
Naproxen—CYP2C8—Dexamethasone—ankylosing spondylitis	0.00532	0.0277	CbGbCtD
Naproxen—CYP2C9—Dexamethasone—ankylosing spondylitis	0.00371	0.0193	CbGbCtD
Naproxen—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000211	0.159	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000208	0.156	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000208	0.156	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000203	0.153	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	0.000127	0.0957	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	0.000125	0.0942	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	0.000125	0.0942	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	0.000122	0.0921	CbGdCrCtD
Naproxen—Shock—Methylprednisolone—ankylosing spondylitis	4.18e-05	0.000821	CcSEcCtD
Naproxen—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	4.17e-05	0.000819	CcSEcCtD
Naproxen—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	4.17e-05	0.000818	CcSEcCtD
Naproxen—Loss of consciousness—Dexamethasone—ankylosing spondylitis	4.16e-05	0.000817	CcSEcCtD
Naproxen—Loss of consciousness—Betamethasone—ankylosing spondylitis	4.16e-05	0.000817	CcSEcCtD
Naproxen—Epistaxis—Methotrexate—ankylosing spondylitis	4.16e-05	0.000817	CcSEcCtD
Naproxen—Paraesthesia—Prednisolone—ankylosing spondylitis	4.16e-05	0.000817	CcSEcCtD
Naproxen—Tachycardia—Triamcinolone—ankylosing spondylitis	4.16e-05	0.000816	CcSEcCtD
Naproxen—Mental disorder—Prednisone—ankylosing spondylitis	4.15e-05	0.000815	CcSEcCtD
Naproxen—Tachycardia—Methylprednisolone—ankylosing spondylitis	4.15e-05	0.000814	CcSEcCtD
Naproxen—Skin disorder—Methylprednisolone—ankylosing spondylitis	4.13e-05	0.000811	CcSEcCtD
Naproxen—Malnutrition—Prednisone—ankylosing spondylitis	4.12e-05	0.00081	CcSEcCtD
Naproxen—Erythema—Prednisone—ankylosing spondylitis	4.12e-05	0.00081	CcSEcCtD
Naproxen—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	4.12e-05	0.000808	CcSEcCtD
Naproxen—Agranulocytosis—Methotrexate—ankylosing spondylitis	4.11e-05	0.000808	CcSEcCtD
Naproxen—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	4.11e-05	0.000807	CcSEcCtD
Naproxen—Convulsion—Betamethasone—ankylosing spondylitis	4.1e-05	0.000806	CcSEcCtD
Naproxen—Convulsion—Dexamethasone—ankylosing spondylitis	4.1e-05	0.000806	CcSEcCtD
Naproxen—Hypertension—Betamethasone—ankylosing spondylitis	4.09e-05	0.000803	CcSEcCtD
Naproxen—Hypertension—Dexamethasone—ankylosing spondylitis	4.09e-05	0.000803	CcSEcCtD
Naproxen—Myalgia—Betamethasone—ankylosing spondylitis	4.03e-05	0.000792	CcSEcCtD
Naproxen—Myalgia—Dexamethasone—ankylosing spondylitis	4.03e-05	0.000792	CcSEcCtD
Naproxen—Anxiety—Dexamethasone—ankylosing spondylitis	4.02e-05	0.000789	CcSEcCtD
Naproxen—Anxiety—Betamethasone—ankylosing spondylitis	4.02e-05	0.000789	CcSEcCtD
Naproxen—Discomfort—Dexamethasone—ankylosing spondylitis	3.98e-05	0.000782	CcSEcCtD
Naproxen—Discomfort—Betamethasone—ankylosing spondylitis	3.98e-05	0.000782	CcSEcCtD
Naproxen—Haemoglobin—Methotrexate—ankylosing spondylitis	3.98e-05	0.000781	CcSEcCtD
Naproxen—Hypotension—Methylprednisolone—ankylosing spondylitis	3.97e-05	0.00078	CcSEcCtD
Naproxen—Pain—Prednisolone—ankylosing spondylitis	3.96e-05	0.000778	CcSEcCtD
Naproxen—Haemorrhage—Methotrexate—ankylosing spondylitis	3.96e-05	0.000777	CcSEcCtD
Naproxen—Hepatitis—Methotrexate—ankylosing spondylitis	3.96e-05	0.000777	CcSEcCtD
Naproxen—Pharyngitis—Methotrexate—ankylosing spondylitis	3.93e-05	0.000772	CcSEcCtD
Naproxen—Urinary tract disorder—Methotrexate—ankylosing spondylitis	3.91e-05	0.000768	CcSEcCtD
Naproxen—Vision blurred—Prednisone—ankylosing spondylitis	3.89e-05	0.000763	CcSEcCtD
Naproxen—Urethral disorder—Methotrexate—ankylosing spondylitis	3.88e-05	0.000762	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	3.88e-05	0.000762	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	3.87e-05	0.00076	CcSEcCtD
Naproxen—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	3.86e-05	0.000759	CcSEcCtD
Naproxen—Oedema—Betamethasone—ankylosing spondylitis	3.86e-05	0.000759	CcSEcCtD
Naproxen—Anaphylactic shock—Betamethasone—ankylosing spondylitis	3.86e-05	0.000759	CcSEcCtD
Naproxen—Oedema—Dexamethasone—ankylosing spondylitis	3.86e-05	0.000759	CcSEcCtD
Naproxen—Insomnia—Triamcinolone—ankylosing spondylitis	3.85e-05	0.000756	CcSEcCtD
Naproxen—Insomnia—Methylprednisolone—ankylosing spondylitis	3.84e-05	0.000755	CcSEcCtD
Naproxen—Infection—Dexamethasone—ankylosing spondylitis	3.84e-05	0.000754	CcSEcCtD
Naproxen—Infection—Betamethasone—ankylosing spondylitis	3.84e-05	0.000754	CcSEcCtD
Naproxen—Ill-defined disorder—Prednisone—ankylosing spondylitis	3.83e-05	0.000751	CcSEcCtD
Naproxen—Paraesthesia—Triamcinolone—ankylosing spondylitis	3.82e-05	0.000751	CcSEcCtD
Naproxen—Feeling abnormal—Prednisolone—ankylosing spondylitis	3.82e-05	0.000749	CcSEcCtD
Naproxen—Paraesthesia—Methylprednisolone—ankylosing spondylitis	3.82e-05	0.000749	CcSEcCtD
Naproxen—Visual impairment—Methotrexate—ankylosing spondylitis	3.81e-05	0.000749	CcSEcCtD
Naproxen—Anaemia—Prednisone—ankylosing spondylitis	3.81e-05	0.000748	CcSEcCtD
Naproxen—Shock—Betamethasone—ankylosing spondylitis	3.8e-05	0.000747	CcSEcCtD
Naproxen—Shock—Dexamethasone—ankylosing spondylitis	3.8e-05	0.000747	CcSEcCtD
Naproxen—Dyspnoea—Triamcinolone—ankylosing spondylitis	3.8e-05	0.000746	CcSEcCtD
Naproxen—Nervous system disorder—Dexamethasone—ankylosing spondylitis	3.79e-05	0.000744	CcSEcCtD
Naproxen—Nervous system disorder—Betamethasone—ankylosing spondylitis	3.79e-05	0.000744	CcSEcCtD
Naproxen—Thrombocytopenia—Betamethasone—ankylosing spondylitis	3.78e-05	0.000743	CcSEcCtD
Naproxen—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	3.78e-05	0.000743	CcSEcCtD
Naproxen—Tachycardia—Dexamethasone—ankylosing spondylitis	3.77e-05	0.000741	CcSEcCtD
Naproxen—Tachycardia—Betamethasone—ankylosing spondylitis	3.77e-05	0.000741	CcSEcCtD
Naproxen—Angioedema—Prednisone—ankylosing spondylitis	3.77e-05	0.00074	CcSEcCtD
Naproxen—Dyspepsia—Triamcinolone—ankylosing spondylitis	3.75e-05	0.000736	CcSEcCtD
Naproxen—Erythema multiforme—Methotrexate—ankylosing spondylitis	3.74e-05	0.000735	CcSEcCtD
Naproxen—Dyspepsia—Methylprednisolone—ankylosing spondylitis	3.74e-05	0.000735	CcSEcCtD
Naproxen—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	3.74e-05	0.000734	CcSEcCtD
Naproxen—Hyperhidrosis—Betamethasone—ankylosing spondylitis	3.74e-05	0.000734	CcSEcCtD
Naproxen—Malaise—Prednisone—ankylosing spondylitis	3.72e-05	0.00073	CcSEcCtD
Naproxen—Vertigo—Prednisone—ankylosing spondylitis	3.7e-05	0.000727	CcSEcCtD
Naproxen—Eye disorder—Methotrexate—ankylosing spondylitis	3.7e-05	0.000726	CcSEcCtD
Naproxen—Syncope—Prednisone—ankylosing spondylitis	3.7e-05	0.000726	CcSEcCtD
Naproxen—Tinnitus—Methotrexate—ankylosing spondylitis	3.69e-05	0.000725	CcSEcCtD
Naproxen—Anorexia—Dexamethasone—ankylosing spondylitis	3.68e-05	0.000723	CcSEcCtD
Naproxen—Anorexia—Betamethasone—ankylosing spondylitis	3.68e-05	0.000723	CcSEcCtD
Naproxen—Urticaria—Prednisolone—ankylosing spondylitis	3.68e-05	0.000722	CcSEcCtD
Naproxen—Cardiac disorder—Methotrexate—ankylosing spondylitis	3.67e-05	0.000721	CcSEcCtD
Naproxen—Fatigue—Triamcinolone—ankylosing spondylitis	3.67e-05	0.000721	CcSEcCtD
Naproxen—Fatigue—Methylprednisolone—ankylosing spondylitis	3.66e-05	0.000719	CcSEcCtD
Naproxen—Pain—Triamcinolone—ankylosing spondylitis	3.64e-05	0.000715	CcSEcCtD
Naproxen—Loss of consciousness—Prednisone—ankylosing spondylitis	3.62e-05	0.000712	CcSEcCtD
Naproxen—Hypotension—Betamethasone—ankylosing spondylitis	3.61e-05	0.000709	CcSEcCtD
Naproxen—Hypotension—Dexamethasone—ankylosing spondylitis	3.61e-05	0.000709	CcSEcCtD
Naproxen—Angiopathy—Methotrexate—ankylosing spondylitis	3.59e-05	0.000705	CcSEcCtD
Naproxen—Immune system disorder—Methotrexate—ankylosing spondylitis	3.58e-05	0.000702	CcSEcCtD
Naproxen—Convulsion—Prednisone—ankylosing spondylitis	3.57e-05	0.000702	CcSEcCtD
Naproxen—Mediastinal disorder—Methotrexate—ankylosing spondylitis	3.57e-05	0.000701	CcSEcCtD
Naproxen—Hypertension—Prednisone—ankylosing spondylitis	3.56e-05	0.000699	CcSEcCtD
Naproxen—Chills—Methotrexate—ankylosing spondylitis	3.55e-05	0.000698	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	3.52e-05	0.000691	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	3.52e-05	0.000691	CcSEcCtD
Naproxen—Myalgia—Prednisone—ankylosing spondylitis	3.51e-05	0.000689	CcSEcCtD
Naproxen—Arthralgia—Prednisone—ankylosing spondylitis	3.51e-05	0.000689	CcSEcCtD
Naproxen—Feeling abnormal—Triamcinolone—ankylosing spondylitis	3.51e-05	0.000689	CcSEcCtD
Naproxen—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	3.5e-05	0.000688	CcSEcCtD
Naproxen—Anxiety—Prednisone—ankylosing spondylitis	3.5e-05	0.000687	CcSEcCtD
Naproxen—Alopecia—Methotrexate—ankylosing spondylitis	3.5e-05	0.000687	CcSEcCtD
Naproxen—Insomnia—Betamethasone—ankylosing spondylitis	3.49e-05	0.000686	CcSEcCtD
Naproxen—Insomnia—Dexamethasone—ankylosing spondylitis	3.49e-05	0.000686	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	3.49e-05	0.000685	CcSEcCtD
Naproxen—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	3.47e-05	0.000682	CcSEcCtD
Naproxen—Paraesthesia—Dexamethasone—ankylosing spondylitis	3.47e-05	0.000681	CcSEcCtD
Naproxen—Paraesthesia—Betamethasone—ankylosing spondylitis	3.47e-05	0.000681	CcSEcCtD
Naproxen—Discomfort—Prednisone—ankylosing spondylitis	3.47e-05	0.000681	CcSEcCtD
Naproxen—Mental disorder—Methotrexate—ankylosing spondylitis	3.47e-05	0.000681	CcSEcCtD
Naproxen—Malnutrition—Methotrexate—ankylosing spondylitis	3.45e-05	0.000677	CcSEcCtD
Naproxen—Erythema—Methotrexate—ankylosing spondylitis	3.45e-05	0.000677	CcSEcCtD
Naproxen—Hypersensitivity—Prednisolone—ankylosing spondylitis	3.41e-05	0.00067	CcSEcCtD
Naproxen—Dyspepsia—Betamethasone—ankylosing spondylitis	3.4e-05	0.000668	CcSEcCtD
Naproxen—Dyspepsia—Dexamethasone—ankylosing spondylitis	3.4e-05	0.000668	CcSEcCtD
Naproxen—Urticaria—Triamcinolone—ankylosing spondylitis	3.38e-05	0.000664	CcSEcCtD
Naproxen—Urticaria—Methylprednisolone—ankylosing spondylitis	3.38e-05	0.000663	CcSEcCtD
Naproxen—Body temperature increased—Triamcinolone—ankylosing spondylitis	3.37e-05	0.000661	CcSEcCtD
Naproxen—Oedema—Prednisone—ankylosing spondylitis	3.36e-05	0.000661	CcSEcCtD
Naproxen—Anaphylactic shock—Prednisone—ankylosing spondylitis	3.36e-05	0.000661	CcSEcCtD
Naproxen—Abdominal pain—Methylprednisolone—ankylosing spondylitis	3.36e-05	0.00066	CcSEcCtD
Naproxen—Decreased appetite—Betamethasone—ankylosing spondylitis	3.36e-05	0.00066	CcSEcCtD
Naproxen—Decreased appetite—Dexamethasone—ankylosing spondylitis	3.36e-05	0.00066	CcSEcCtD
Naproxen—Infection—Prednisone—ankylosing spondylitis	3.34e-05	0.000657	CcSEcCtD
Naproxen—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	3.34e-05	0.000655	CcSEcCtD
Naproxen—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	3.34e-05	0.000655	CcSEcCtD
Naproxen—Fatigue—Betamethasone—ankylosing spondylitis	3.33e-05	0.000654	CcSEcCtD
Naproxen—Fatigue—Dexamethasone—ankylosing spondylitis	3.33e-05	0.000654	CcSEcCtD
Naproxen—Shock—Prednisone—ankylosing spondylitis	3.31e-05	0.00065	CcSEcCtD
Naproxen—Pain—Betamethasone—ankylosing spondylitis	3.3e-05	0.000649	CcSEcCtD
Naproxen—Pain—Dexamethasone—ankylosing spondylitis	3.3e-05	0.000649	CcSEcCtD
Naproxen—Nervous system disorder—Prednisone—ankylosing spondylitis	3.3e-05	0.000648	CcSEcCtD
Naproxen—Tachycardia—Prednisone—ankylosing spondylitis	3.28e-05	0.000645	CcSEcCtD
Naproxen—Skin disorder—Prednisone—ankylosing spondylitis	3.27e-05	0.000642	CcSEcCtD
Naproxen—Hyperhidrosis—Prednisone—ankylosing spondylitis	3.25e-05	0.000639	CcSEcCtD
Naproxen—Vision blurred—Methotrexate—ankylosing spondylitis	3.25e-05	0.000638	CcSEcCtD
Naproxen—Anorexia—Prednisone—ankylosing spondylitis	3.21e-05	0.00063	CcSEcCtD
Naproxen—Ill-defined disorder—Methotrexate—ankylosing spondylitis	3.2e-05	0.000628	CcSEcCtD
Naproxen—Anaemia—Methotrexate—ankylosing spondylitis	3.18e-05	0.000625	CcSEcCtD
Naproxen—Feeling abnormal—Dexamethasone—ankylosing spondylitis	3.18e-05	0.000625	CcSEcCtD
Naproxen—Feeling abnormal—Betamethasone—ankylosing spondylitis	3.18e-05	0.000625	CcSEcCtD
Naproxen—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	3.16e-05	0.000621	CcSEcCtD
Naproxen—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	3.16e-05	0.000621	CcSEcCtD
Naproxen—Hypersensitivity—Triamcinolone—ankylosing spondylitis	3.14e-05	0.000616	CcSEcCtD
Naproxen—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	3.13e-05	0.000615	CcSEcCtD
Naproxen—Malaise—Methotrexate—ankylosing spondylitis	3.11e-05	0.00061	CcSEcCtD
Naproxen—Vertigo—Methotrexate—ankylosing spondylitis	3.1e-05	0.000608	CcSEcCtD
Naproxen—Leukopenia—Methotrexate—ankylosing spondylitis	3.08e-05	0.000606	CcSEcCtD
Naproxen—Urticaria—Dexamethasone—ankylosing spondylitis	3.07e-05	0.000603	CcSEcCtD
Naproxen—Urticaria—Betamethasone—ankylosing spondylitis	3.07e-05	0.000603	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	3.07e-05	0.000602	CcSEcCtD
Naproxen—Dizziness—Prednisolone—ankylosing spondylitis	3.06e-05	0.000601	CcSEcCtD
Naproxen—Asthenia—Triamcinolone—ankylosing spondylitis	3.06e-05	0.0006	CcSEcCtD
Naproxen—Body temperature increased—Dexamethasone—ankylosing spondylitis	3.05e-05	0.0006	CcSEcCtD
Naproxen—Abdominal pain—Betamethasone—ankylosing spondylitis	3.05e-05	0.0006	CcSEcCtD
Naproxen—Abdominal pain—Dexamethasone—ankylosing spondylitis	3.05e-05	0.0006	CcSEcCtD
Naproxen—Body temperature increased—Betamethasone—ankylosing spondylitis	3.05e-05	0.0006	CcSEcCtD
Naproxen—Asthenia—Methylprednisolone—ankylosing spondylitis	3.05e-05	0.000599	CcSEcCtD
Naproxen—Insomnia—Prednisone—ankylosing spondylitis	3.04e-05	0.000598	CcSEcCtD
Naproxen—Paraesthesia—Prednisone—ankylosing spondylitis	3.02e-05	0.000593	CcSEcCtD
Naproxen—Pruritus—Triamcinolone—ankylosing spondylitis	3.01e-05	0.000592	CcSEcCtD
Naproxen—Cough—Methotrexate—ankylosing spondylitis	3.01e-05	0.000591	CcSEcCtD
Naproxen—Pruritus—Methylprednisolone—ankylosing spondylitis	3.01e-05	0.00059	CcSEcCtD
Naproxen—Convulsion—Methotrexate—ankylosing spondylitis	2.99e-05	0.000586	CcSEcCtD
Naproxen—Dyspepsia—Prednisone—ankylosing spondylitis	2.96e-05	0.000582	CcSEcCtD
Naproxen—Chest pain—Methotrexate—ankylosing spondylitis	2.93e-05	0.000576	CcSEcCtD
Naproxen—Arthralgia—Methotrexate—ankylosing spondylitis	2.93e-05	0.000576	CcSEcCtD
Naproxen—Myalgia—Methotrexate—ankylosing spondylitis	2.93e-05	0.000576	CcSEcCtD
Naproxen—Decreased appetite—Prednisone—ankylosing spondylitis	2.92e-05	0.000574	CcSEcCtD
Naproxen—Rash—Prednisolone—ankylosing spondylitis	2.92e-05	0.000573	CcSEcCtD
Naproxen—Dermatitis—Prednisolone—ankylosing spondylitis	2.92e-05	0.000573	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	2.91e-05	0.000572	CcSEcCtD
Naproxen—Diarrhoea—Methylprednisolone—ankylosing spondylitis	2.91e-05	0.000571	CcSEcCtD
Naproxen—Fatigue—Prednisone—ankylosing spondylitis	2.9e-05	0.00057	CcSEcCtD
Naproxen—Headache—Prednisolone—ankylosing spondylitis	2.9e-05	0.00057	CcSEcCtD
Naproxen—Discomfort—Methotrexate—ankylosing spondylitis	2.9e-05	0.000569	CcSEcCtD
Naproxen—Constipation—Prednisone—ankylosing spondylitis	2.88e-05	0.000565	CcSEcCtD
Naproxen—Confusional state—Methotrexate—ankylosing spondylitis	2.84e-05	0.000557	CcSEcCtD
Naproxen—Dizziness—Triamcinolone—ankylosing spondylitis	2.82e-05	0.000553	CcSEcCtD
Naproxen—Anaphylactic shock—Methotrexate—ankylosing spondylitis	2.81e-05	0.000552	CcSEcCtD
Naproxen—Dizziness—Methylprednisolone—ankylosing spondylitis	2.81e-05	0.000552	CcSEcCtD
Naproxen—Infection—Methotrexate—ankylosing spondylitis	2.79e-05	0.000549	CcSEcCtD
Naproxen—Feeling abnormal—Prednisone—ankylosing spondylitis	2.77e-05	0.000545	CcSEcCtD
Naproxen—Asthenia—Dexamethasone—ankylosing spondylitis	2.77e-05	0.000544	CcSEcCtD
Naproxen—Asthenia—Betamethasone—ankylosing spondylitis	2.77e-05	0.000544	CcSEcCtD
Naproxen—Nervous system disorder—Methotrexate—ankylosing spondylitis	2.76e-05	0.000542	CcSEcCtD
Naproxen—Thrombocytopenia—Methotrexate—ankylosing spondylitis	2.75e-05	0.000541	CcSEcCtD
Naproxen—Gastrointestinal pain—Prednisone—ankylosing spondylitis	2.75e-05	0.00054	CcSEcCtD
Naproxen—Nausea—Prednisolone—ankylosing spondylitis	2.75e-05	0.00054	CcSEcCtD
Naproxen—Pruritus—Betamethasone—ankylosing spondylitis	2.73e-05	0.000537	CcSEcCtD
Naproxen—Pruritus—Dexamethasone—ankylosing spondylitis	2.73e-05	0.000537	CcSEcCtD
Naproxen—Skin disorder—Methotrexate—ankylosing spondylitis	2.73e-05	0.000536	CcSEcCtD
Naproxen—Hyperhidrosis—Methotrexate—ankylosing spondylitis	2.72e-05	0.000534	CcSEcCtD
Naproxen—Vomiting—Triamcinolone—ankylosing spondylitis	2.71e-05	0.000532	CcSEcCtD
Naproxen—Vomiting—Methylprednisolone—ankylosing spondylitis	2.7e-05	0.000531	CcSEcCtD
Naproxen—Rash—Triamcinolone—ankylosing spondylitis	2.68e-05	0.000527	CcSEcCtD
Naproxen—Dermatitis—Triamcinolone—ankylosing spondylitis	2.68e-05	0.000527	CcSEcCtD
Naproxen—Anorexia—Methotrexate—ankylosing spondylitis	2.68e-05	0.000526	CcSEcCtD
Naproxen—Rash—Methylprednisolone—ankylosing spondylitis	2.68e-05	0.000526	CcSEcCtD
Naproxen—Dermatitis—Methylprednisolone—ankylosing spondylitis	2.68e-05	0.000526	CcSEcCtD
Naproxen—Urticaria—Prednisone—ankylosing spondylitis	2.67e-05	0.000525	CcSEcCtD
Naproxen—Headache—Triamcinolone—ankylosing spondylitis	2.67e-05	0.000524	CcSEcCtD
Naproxen—Headache—Methylprednisolone—ankylosing spondylitis	2.66e-05	0.000523	CcSEcCtD
Naproxen—Abdominal pain—Prednisone—ankylosing spondylitis	2.66e-05	0.000522	CcSEcCtD
Naproxen—Body temperature increased—Prednisone—ankylosing spondylitis	2.66e-05	0.000522	CcSEcCtD
Naproxen—Diarrhoea—Betamethasone—ankylosing spondylitis	2.64e-05	0.000519	CcSEcCtD
Naproxen—Diarrhoea—Dexamethasone—ankylosing spondylitis	2.64e-05	0.000519	CcSEcCtD
Naproxen—Hypotension—Methotrexate—ankylosing spondylitis	2.63e-05	0.000516	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	2.56e-05	0.000503	CcSEcCtD
Naproxen—Dizziness—Dexamethasone—ankylosing spondylitis	2.55e-05	0.000502	CcSEcCtD
Naproxen—Dizziness—Betamethasone—ankylosing spondylitis	2.55e-05	0.000502	CcSEcCtD
Naproxen—Insomnia—Methotrexate—ankylosing spondylitis	2.54e-05	0.0005	CcSEcCtD
Naproxen—Nausea—Triamcinolone—ankylosing spondylitis	2.53e-05	0.000497	CcSEcCtD
Naproxen—Paraesthesia—Methotrexate—ankylosing spondylitis	2.52e-05	0.000496	CcSEcCtD
Naproxen—Nausea—Methylprednisolone—ankylosing spondylitis	2.52e-05	0.000496	CcSEcCtD
Naproxen—Dyspnoea—Methotrexate—ankylosing spondylitis	2.51e-05	0.000492	CcSEcCtD
Naproxen—Somnolence—Methotrexate—ankylosing spondylitis	2.5e-05	0.000491	CcSEcCtD
Naproxen—Hypersensitivity—Prednisone—ankylosing spondylitis	2.48e-05	0.000487	CcSEcCtD
Naproxen—Dyspepsia—Methotrexate—ankylosing spondylitis	2.48e-05	0.000486	CcSEcCtD
Naproxen—Vomiting—Betamethasone—ankylosing spondylitis	2.46e-05	0.000482	CcSEcCtD
Naproxen—Vomiting—Dexamethasone—ankylosing spondylitis	2.46e-05	0.000482	CcSEcCtD
Naproxen—Decreased appetite—Methotrexate—ankylosing spondylitis	2.44e-05	0.00048	CcSEcCtD
Naproxen—Rash—Betamethasone—ankylosing spondylitis	2.44e-05	0.000478	CcSEcCtD
Naproxen—Rash—Dexamethasone—ankylosing spondylitis	2.44e-05	0.000478	CcSEcCtD
Naproxen—Dermatitis—Betamethasone—ankylosing spondylitis	2.43e-05	0.000478	CcSEcCtD
Naproxen—Dermatitis—Dexamethasone—ankylosing spondylitis	2.43e-05	0.000478	CcSEcCtD
Naproxen—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	2.43e-05	0.000477	CcSEcCtD
Naproxen—Fatigue—Methotrexate—ankylosing spondylitis	2.42e-05	0.000476	CcSEcCtD
Naproxen—Headache—Dexamethasone—ankylosing spondylitis	2.42e-05	0.000475	CcSEcCtD
Naproxen—Headache—Betamethasone—ankylosing spondylitis	2.42e-05	0.000475	CcSEcCtD
Naproxen—Asthenia—Prednisone—ankylosing spondylitis	2.41e-05	0.000474	CcSEcCtD
Naproxen—Pain—Methotrexate—ankylosing spondylitis	2.4e-05	0.000472	CcSEcCtD
Naproxen—Pruritus—Prednisone—ankylosing spondylitis	2.38e-05	0.000468	CcSEcCtD
Naproxen—Feeling abnormal—Methotrexate—ankylosing spondylitis	2.32e-05	0.000455	CcSEcCtD
Naproxen—Diarrhoea—Prednisone—ankylosing spondylitis	2.3e-05	0.000452	CcSEcCtD
Naproxen—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	2.3e-05	0.000452	CcSEcCtD
Naproxen—Nausea—Betamethasone—ankylosing spondylitis	2.29e-05	0.000451	CcSEcCtD
Naproxen—Nausea—Dexamethasone—ankylosing spondylitis	2.29e-05	0.000451	CcSEcCtD
Naproxen—Urticaria—Methotrexate—ankylosing spondylitis	2.23e-05	0.000439	CcSEcCtD
Naproxen—Dizziness—Prednisone—ankylosing spondylitis	2.22e-05	0.000437	CcSEcCtD
Naproxen—Body temperature increased—Methotrexate—ankylosing spondylitis	2.22e-05	0.000437	CcSEcCtD
Naproxen—Abdominal pain—Methotrexate—ankylosing spondylitis	2.22e-05	0.000437	CcSEcCtD
Naproxen—Vomiting—Prednisone—ankylosing spondylitis	2.14e-05	0.00042	CcSEcCtD
Naproxen—Rash—Prednisone—ankylosing spondylitis	2.12e-05	0.000417	CcSEcCtD
Naproxen—Dermatitis—Prednisone—ankylosing spondylitis	2.12e-05	0.000416	CcSEcCtD
Naproxen—Headache—Prednisone—ankylosing spondylitis	2.11e-05	0.000414	CcSEcCtD
Naproxen—Hypersensitivity—Methotrexate—ankylosing spondylitis	2.07e-05	0.000407	CcSEcCtD
Naproxen—Asthenia—Methotrexate—ankylosing spondylitis	2.02e-05	0.000396	CcSEcCtD
Naproxen—Nausea—Prednisone—ankylosing spondylitis	2e-05	0.000393	CcSEcCtD
Naproxen—Pruritus—Methotrexate—ankylosing spondylitis	1.99e-05	0.000391	CcSEcCtD
Naproxen—Diarrhoea—Methotrexate—ankylosing spondylitis	1.92e-05	0.000378	CcSEcCtD
Naproxen—Dizziness—Methotrexate—ankylosing spondylitis	1.86e-05	0.000365	CcSEcCtD
Naproxen—Vomiting—Methotrexate—ankylosing spondylitis	1.79e-05	0.000351	CcSEcCtD
Naproxen—Rash—Methotrexate—ankylosing spondylitis	1.77e-05	0.000348	CcSEcCtD
Naproxen—Dermatitis—Methotrexate—ankylosing spondylitis	1.77e-05	0.000348	CcSEcCtD
Naproxen—Headache—Methotrexate—ankylosing spondylitis	1.76e-05	0.000346	CcSEcCtD
Naproxen—Nausea—Methotrexate—ankylosing spondylitis	1.67e-05	0.000328	CcSEcCtD
